LRRK2 and Parkinson disease: Two studies using a neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), as a PD model, have described the role of long non-coding RNA in controlling the expression and abundance of LRRK2.